4527:TSERohto Pharmaceutical Co., Ltd. Analysis
Data as of 2026-08-01 - not real-time
NT$39.00
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Kuen Ling Machinery trades around TWD 39, well below its DCF‑derived fair value of roughly TWD 93, indicating a substantial discount. The stock’s trailing PE of 11.6 is dramatically lower than the industry average of 32.8, underscoring its relative cheapness. With a dividend yield near 7.7% and a payout ratio of about 95%, the company offers one of the highest cash returns on the market. Strong balance‑sheet metrics—cash of TWD 1.15 bn versus debt of only TWD 0.21 bn and a debt‑to‑equity of just 12%—provide ample headroom to sustain the payout. Operating margins sit at 10.4% and free cash flow exceeds earnings, supporting the view that cash generation is healthy. However, revenue has contracted 5.6% year‑over‑year, reflecting a modest slowdown in the cooling‑equipment segment.
Technically, the 20‑day SMA (≈39.23) sits just above the current price, while the 50‑day and 200‑day SMAs remain higher, signaling a bearish bias. The RSI of 38.9 suggests the stock is not yet oversold, and the MACD histogram shows a tiny bullish tilt, hinting at a possible short‑term rebound. Volume has been trending lower, and the price is flirting with a support level near TWD 38.7, adding pressure to the near‑term outlook. The beta of 0.08 and 30‑day volatility of about 11% point to a very defensive price profile, limiting downside risk. Given the stark valuation gap, solid cash flow and dividend attractiveness, the stock appears compelling for investors with a medium‑ to long‑term horizon. Nonetheless, the current bearish technical setup and shrinking trading activity counsel caution in the short run.
Technically, the 20‑day SMA (≈39.23) sits just above the current price, while the 50‑day and 200‑day SMAs remain higher, signaling a bearish bias. The RSI of 38.9 suggests the stock is not yet oversold, and the MACD histogram shows a tiny bullish tilt, hinting at a possible short‑term rebound. Volume has been trending lower, and the price is flirting with a support level near TWD 38.7, adding pressure to the near‑term outlook. The beta of 0.08 and 30‑day volatility of about 11% point to a very defensive price profile, limiting downside risk. Given the stark valuation gap, solid cash flow and dividend attractiveness, the stock appears compelling for investors with a medium‑ to long‑term horizon. Nonetheless, the current bearish technical setup and shrinking trading activity counsel caution in the short run.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical trend
- Price near support
- Decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation gap
- Low PE vs industry
- Strong cash flow and low leverage
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable high dividend yield
- Defensive beta and volatility
- Long‑term demand for cooling solutions
Key Metrics & Analysis
Financial Health
Revenue Growth-5.60%
Profit Margin8.89%
P/E Ratio11.6
ROE15.27%
ROA5.83%
Debt/Equity12.18
P/B Ratio1.8
Op. Cash FlowNT$629.3M
Free Cash FlowNT$477.9M
Industry P/E32.8
Technical Analysis
TrendBearish
RSI38.9
SupportNT$38.70
ResistanceNT$40.55
MA 20NT$39.23
MA 50NT$40.61
MA 200NT$40.80
MACDBullish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Fair ValueNT$92.76
GradeUndervalued
TypeValue
Dividend Yield7.69%
Risk Assessment
Beta0.08
Volatility11.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.